Title
Update on the epidemiology of carbapenemases in Latin America and the Caribbean
Date Issued
01 January 2021
Access level
metadata only access
Resource Type
review
Author(s)
García-Betancur J.C.
Appel T.M.
Esparza G.
Gales A.C.
Levy-Hara G.
Cornistein W.
Vega S.
Nuñez D.
Bavestrello L.
Castañeda-Méndez P.F.
Villalobos-Vindas J.M.
Villegas M.V.
Publisher(s)
Taylor and Francis Ltd.
Abstract
Introduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D. Areas covered: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean. Expert opinion: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy.
Start page
197
End page
213
Volume
19
Issue
2
Language
English
OCDE Knowledge area
Epidemiología Parasitología Oncología Tecnología para la identificación y funcionamiento del ADN, proteínas y enzimas y como influencian la enfermedad)
Scopus EID
2-s2.0-85090951235
PubMed ID
Source
Expert Review of Anti-Infective Therapy
ISSN of the container
14787210
Sources of information: Directorio de Producción Científica Scopus